Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

RE104 Safety and Efficacy Study in Postpartum Depression

ClinicalTrials.gov ID: NCT06342310

Public ClinicalTrials.gov record NCT06342310. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Parallel-Group Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Patients With Postpartum Depression (PPD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms in participants with moderate-to-severe postpartum depression (PPD) as compared to active-control.

Study identification

NCT ID
NCT06342310
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Reunion Neuroscience Inc
Industry
Enrollment
84 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 14, 2024 (Actual)
Primary completion
May 22, 2025 (Actual)
Completion
Jun 16, 2025 (Actual)
Last update posted
May 14, 2026

2024 – 2025

United States locations

U.S. sites
38
U.S. states
22
U.S. cities
34
Facility City State ZIP Site status
Reunion Investigational Site Birmingham Alabama 35209 —
Reunion Investigational Site Tucson Arizona 85724 —
Reunion Investigational Site Santa Monica California 90404 —
Reunion Investigational Site Boulder Colorado 80045 —
Reunion Investigational Site Denver Colorado 80209 —
Reunion Investigational Site Lauderhill Florida 33319 —
Reunion Investigational Site Tampa Florida 33613 —
Reunion Investigational Site Atlanta Georgia 30329 —
Reunion Investigational Site Atlanta Georgia 30331 —
Reunion Investigational Site Decatur Georgia 30030 —
Reunion Investigational Site Marietta Georgia 30060 —
Reunion Investigational Site Savannah Georgia 31405 —
Reunion Investigational Site Honolulu Hawaii 96817 —
Reunion Investigational Site Kansas City Kansas 66160 —
Reunion Investigational Site Shreveport Louisiana 71106 —
Reunion Investigational Site Baltimore Maryland 21205 —
Reunion Investigational Site Rockville Maryland 20850 —
Reunion Investigational Site Springfield Massachusetts 01103 —
Reunion Investigational Site Novi Michigan 48377 —
Reunion Investigational Site Albuquerque New Mexico 87131 —
Reunion Investigational Site Buffalo New York 14202 —
Reunion Investigational Site New York New York 10016 —
Reunion Investigational Site New York New York 10026 —
Reunion Investigational Site Chapel Hill North Carolina 27599 —
Reunion Investigational Site Monroe North Carolina 28112 —
Reunion Investigational Site Cleveland Ohio 44113 —
Reunion Investigational Site Columbus Ohio 43210 —
Reunion Investigational Site West Chester Pennsylvania 19380 —
Reunion Investigational Site Austin Texas 78712 —
Reunion Investigational Site Austin Texas 78737 —
Reunion Investigational Site Austin Texas 78759 —
Reunion Investigational Site Plano Texas 75093 —
Reunion Investigational Site San Antonio Texas 78229 —
Reunion Investigational Site Draper Utah 84020 —
Reunion Investigational Site Salt Lake City Utah 84108 —
Reunion Investigational Site Charlottesville Virginia 22903 —
Reunion Investigational Site Seattle Washington 98105 —
Reunion Investigational Site Madison Wisconsin 53719 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06342310, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06342310 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →